More study data available!
Data has been uploaded for 3 pre-clinical studies including:
- CAVD 278 (Lewis) — study of a panel of anti-gp41 monoclonal antibodies that mediate ADCC.
- CAVD 569 (Nussenzweig) — study of Fc-modified and bispecific monoclonal antibodies.
- CAVD 708 (McElrath) — Guinea pig study comparing BG505 SOSIP.664 protein formulated with different adjuvants.
Click on the study page links below for Protocol Team reports, data summaries, and more details about the studies.
Data was uploaded for the following studies:
|
Name & Description |
Data Added |
Type |
PI |
Strategy |
|
CAVD 278 (CAVIMC-040) is an immunogenicity study to define the epitopes recognized by a panel of anti-gp41 monoclonal antibodies that mediate ADCC |
NAB MAB |
Antibody Screening |
George Lewis |
Prophylactic neutralizing Ab |
|
CAVD 569 is an immunogenicity study of Fc-modified and bispecific broadly neutralizing antibodies |
NAB MAB |
Antibody Screening |
Michel Nussenzweig |
Prophylactic neutralizing Ab |
|
CAVD 708 is a preclinical guinea pig study assessing antibody responses to the HIV BG505 SOSIP.664 protein formulated with different adjuvants |
BAMA, NAB |
Pre-Clinical Guinea pig |
Julie McElrath |
Protein and peptide vaccines |